EXPORT CITATION

Chapter-36 Anti-Inflammatory Therapy for Rhinosinusitis

BOOK TITLE: Sataloff’s Comprehensive Textbook of Otolaryngology: Head & Neck Surgery (Rhinology/Allergy and Immunology) -Volume 2

Author
1. Solyar Alla Y
2. Lanza Donald C
ISBN
9789351524564
DOI
10.5005/jp/books/12714_37
Edition
1/e
Publishing Year
2016
Pages
16
Author Affiliations
1. Sinus and Nasal Institute of Florida, St. Petersburg, Florida, USA
2. Sinus and Nasal Institute of Florida Foundation, Saint Petersburg, Florida, USA
Chapter keywords
sinus inflammation, laryngopharyngeal reflux, histophotomicrograph, respiratory epithelium, pathophysiology, vascular proliferation, mood disorders, mineralocorticoid activity, homeostatic function, antimicrobial therapy, oral corticosteroids, cushingoid features, multimodality therapy, immunosuppressive effects, nasal saline irrigations, sympathomimetic agent

Abstract

This chapter discusses anti-inflammatory therapy for rhinosinusitis, where therapies directed at reducing sinus inflammation include corticosteroids, antihistamines, leukotriene modifiers and antimicrobials with anti-inflammatory properties. Hydrocortisone is naturally produced human glucocorticoid that plays an important role in metabolic, cardiovascular, immunologic, and homeostatic function. Glucocorticoids are a type of corticosteroid hormone that binds the glucocorticoid receptor and possesses anti-inflammatory properties. Oral steroids are recommended for perioperative use in patients with polyps, with multiple studies showing surgical benefits including shorter operative times, improved visibility and improved postoperative appearance, but no significant reduction in blood loss. Multiple studies evaluated the use of oral steroids as an adjunct to surgical treatment. Cushingoid changes include truncal obesity, moon facies, and dorsocervical fat pad known as buffalo hump. Patients using corticosteroid therapy are more likely to complain of peptic ulcer like symptoms. Biologic activity analysis revealed a significant decrease in blood eosinophil counts in the treatment groups.

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved